| Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study L Cabel, F Riva, V Servois, A Livartowski, C Daniel, A Rampanou, O Lantz, ... Annals of Oncology 28 (8), 1996-2001, 2017 | 264 | 2017 |
| The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper M Cristofanilli, JY Pierga, J Reuben, A Rademaker, AA Davis, DJ Peeters, ... Critical reviews in oncology/hematology 134, 39-45, 2019 | 251 | 2019 |
| Circulating tumor cells: clinical validity and utility L Cabel, C Proudhon, H Gortais, D Loirat, F Coussy, JY Pierga, FC Bidard International journal of clinical oncology 22, 421-430, 2017 | 230 | 2017 |
| Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy L Cabel, C Proudhon, E Romano, N Girard, O Lantz, MH Stern, JY Pierga, ... Nature reviews Clinical oncology 15 (10), 639-650, 2018 | 187 | 2018 |
| Clinical utility of circulating tumor cells: An update A Vasseur, N Kiavue, FC Bidard, JY Pierga, L Cabel Molecular oncology 15 (6), 1647-1666, 2021 | 147 | 2021 |
| COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area P Vuagnat, M Frelaut, T Ramtohul, C Basse, S Diakite, A Noret, ... Breast Cancer Research 22, 1-10, 2020 | 140 | 2020 |
| Efficacy of circulating tumor cell count–driven vs clinician-driven first-line therapy choice in hormone receptor–positive, ERBB2-negative metastatic breast cancer: The STIC … FC Bidard, W Jacot, N Kiavue, S Dureau, A Kadi, E Brain, T Bachelot, ... JAMA oncology 7 (1), 34-41, 2021 | 124 | 2021 |
| Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy CS Groeneveld, J Fontugne, L Cabel, I Bernard-Pierrot, F Radvanyi, ... European Journal of Cancer 148, 181-189, 2021 | 104 | 2021 |
| ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics N Kiavue, L Cabel, S Melaabi, G Bataillon, C Callens, F Lerebours, ... Oncogene 39 (3), 487-502, 2020 | 102 | 2020 |
| Circulating tumor cells and circulating tumor DNA detection in potentially resectable metastatic colorectal cancer: a prospective ancillary study to the unicancer prodige-14 trial FC Bidard, N Kiavue, M Ychou, L Cabel, MH Stern, J Madic, A Saliou, ... Cells 8 (6), 516, 2019 | 99 | 2019 |
| Circulating tumor cells in early breast cancer L Thery, A Meddis, L Cabel, C Proudhon, A Latouche, JY Pierga, ... JNCI cancer spectrum 3 (2), pkz026, 2019 | 90 | 2019 |
| Prognostic impact of residual HPV ctDNA detection after chemoradiotherapy for anal squamous cell carcinoma L Cabel, E Jeannot, I Bieche, S Vacher, C Callens, L Bazire, A Morel, ... Clinical Cancer Research 24 (22), 5767-5771, 2018 | 83 | 2018 |
| Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients L Cabel, E Loir, G Gravis, P Lavaud, C Massard, L Albiges, G Baciarello, ... Journal for immunotherapy of cancer 5, 1-6, 2017 | 69 | 2017 |
| Dimethyl fumarate controls the NRF2/DJ-1 axis in cancer cells: therapeutic applications NEB Saidu, G Noé, O Cerles, L Cabel, N Kavian-Tessler, S Chouzenoux, ... Molecular cancer therapeutics 16 (3), 529-539, 2017 | 68 | 2017 |
| ESR1 mutations: a new biomarker in breast cancer M Carausu, FC Bidard, C Callens, S Melaabi, E Jeannot, JY Pierga, ... Expert review of molecular diagnostics 19 (7), 599-611, 2019 | 58 | 2019 |
| High-accuracy determination of microsatellite instability compatible with liquid biopsies AB Silveira, FC Bidard, A Kasperek, S Melaabi, ML Tanguy, M Rodrigues, ... Clinical Chemistry 66 (4), 606-613, 2020 | 56 | 2020 |
| Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients L Darrigues, JY Pierga, A Bernard-Tessier, I Bièche, AB Silveira, M Michel, ... Breast Cancer Research 23, 1-10, 2021 | 52 | 2021 |
| A single droplet digital PCR for ESR1 activating mutations detection in plasma E Jeannot, L Darrigues, M Michel, MH Stern, JY Pierga, A Rampanou, ... Oncogene 39 (14), 2987-2995, 2020 | 48 | 2020 |
| Circulating tumor cells and circulating tumor DNA: what surgical oncologists need to know? L Cabel, C Proudhon, P Mariani, D Tzanis, G Beinse, I Bieche, JY Pierga, ... European Journal of Surgical Oncology (EJSO) 43 (5), 949-962, 2017 | 45 | 2017 |
| Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial L Cabel, F Berger, P Cottu, D Loirat, A Rampanou, E Brain, S Cyrille, ... British Journal of Cancer 124 (7), 1207-1213, 2021 | 44 | 2021 |
